76 results
DEFA14A
SYRS
Syros Pharmaceuticals Inc.
23 Apr 24
Additional proxy soliciting materials
7:05am
Additional Materials
Soliciting Material Pursuant to §240.14a-12
SYROS PHARMACEUTICALS, INC.
(Name of Registrant as Specified in Its Charter)
(Name … with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
+ Online Go
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
Additional Materials
Soliciting Material Pursuant to §240.14a-12
SYROS PHARMACEUTICALS, INC.
(Name of Registrant as Specified in Its Charter)
(Name … with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
PRELIMINARY PROXY
8-K
EX-1.1
0wuft16po 1b
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm
DEFA14A
rnd d8qpgu2ht9uh
21 Apr 23
Additional proxy soliciting materials
7:03am
D
wy6b o8rww
21 Sep 22
$129.84M in equity / options, sold $129.84M, 19 investors
5:07pm
424B3
rglgk
8 Aug 22
Prospectus supplement
5:47pm
S-4/A
EX-99.2
3rbnikz6 11hu2pza
1 Aug 22
Registration of securities issued in business combination transactions (amended)
9:01am
S-4
mv92vwx89yf3fr
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
425
gkh2jbwy3ilfk jgpqy
5 Jul 22
Business combination disclosure
7:14am
8-K
EX-2.1
bzdgp6jvag1
5 Jul 22
Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement
7:07am